1. Zhang, Yuyang, Zhang, Wei, Sun, Lili, Liu, Yang, Zhang, Dan. 2022. HJURP inhibits proliferation of ovarian cancer cells by regulating CENP-A/CENP-N. In Bulletin du cancer, 109, 1007-1016. doi:10.1016/j.bulcan.2021.12.011. https://pubmed.ncbi.nlm.nih.gov/35940943/
2. Zhang, Fan, Yuan, DongBo, Song, JuKun, Chen, Xiaoyue, Zhu, Jianguo. 2021. HJURP is a prognostic biomarker for clear cell renal cell carcinoma and is linked to immune infiltration. In International immunopharmacology, 99, 107899. doi:10.1016/j.intimp.2021.107899. https://pubmed.ncbi.nlm.nih.gov/34217993/
3. Li, Ye, Yi, Qing, Liao, Xiaoli, Li, Yongqiang, Huang, Wenfeng. 2021. Hypomethylation-driven overexpression of HJURP promotes progression of hepatocellular carcinoma and is associated with poor prognosis. In Biochemical and biophysical research communications, 566, 67-74. doi:10.1016/j.bbrc.2021.05.102. https://pubmed.ncbi.nlm.nih.gov/34119827/
4. Hu, Zhi, Huang, Ge, Sadanandam, Anguraj, Gray, Joe W, Mao, Jian-Hua. 2010. The expression level of HJURP has an independent prognostic impact and predicts the sensitivity to radiotherapy in breast cancer. In Breast cancer research : BCR, 12, R18. doi:10.1186/bcr2487. https://pubmed.ncbi.nlm.nih.gov/20211017/
智鼠故事 
